Status:
COMPLETED
The Value of High-resolution Ultrasound in the Detection of Lymph Node Metastasis: a Proposal of NI-RADS
Lead Sponsor:
Peking University People's Hospital
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
18-90 years
Brief Summary
The status of axillary lymph node (ALN) is an important reference indicator for breast cancer surgery and systemic treatment, which is also an important prognostic indicator for breast cancer. Therefo...
Detailed Description
To facilitate the non-invasive assessment of lymph node status preoperatively, we use ultrasound to detect lymph node metastasis. We designed this study to obtain in vivo and vitro ultrasound features...
Eligibility Criteria
Inclusion
- Histologically confirmed invasive breast cancer.
- Pathological axillary lymph node staging planned.
- Axillary lymph node not removed prior to the study.
Exclusion
- Refusal participation in the study.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT03791840
Start Date
December 1 2017
End Date
July 1 2022
Last Update
October 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's Hospital
Beijing, Beijing Municipality, China, 10044